Revlimid: Phase II preliminary data

In a Phase II MDS-003 trial in 148 MDS patients

Read the full 105 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE